Table of Contents for Indian Biotechnology Market Outlook (2006)
1. Biotechnology In India —An Introduction
2. Biotech Sector In India: Bright Future
2.1 India’s Biotechnology Research And Development
2.2 National Biotechnology Development Strategy
2.3 Employment Opportunities In Biotech Sector
2.4 Investments In Indian Biotechnology Sector
2.5 Biotech Parks
2.5.1 Shapoorji Pallonji Biotech Park
2.5.2 ICICI Knowledge Park
2.5.3 International Biotech Park
2.5.4 Lucknow Biotech Park
2.5.5 Ticel Bio Park
2.5.6 Upcoming Parks
3. Government Initiatives And Regulations
3.1 Fiscal Incentives Provided To The Biotech Sector
3.1.1 Tax
3.1.2 Regulatory
3.1.3 Investment
3.2 Important Changes To The Patents Act In The Third Amendment Bill
3.2.1 Substantive Changes
3.2.1.1 Introduction of product patent protection in all fields of technology
3.2.1.2 Deletion of provisions relating to exclusive marketing rights
3.2.1.3 Compulsory License to supply drugs to help needy countries
3.2.2 Procedural Changes
3.2.2.1 Expansion of the jurisdiction of the Appellate Tribunal
3.3 Plant Varieties And Farmers’ Rights Protection Act, 2001
3.4 Other Regulations Impacting The Biotech Sector
3.4.1 Licensing
3.4.2 Clinical Trials
3.4.3 Seeds Act and Policy
3.4.4 Environmental Clearances
3.4.5 Biological Diversity Act
4. Indian Biotechnology Market
4.1 Market Size
4.2 Biotech Domestic And Exports Market
4.3 Growth Forecasts ($ Billions), 2005-2010
5. Market Segmentation
5.1 Biopharmaceuticals
5.2 Bioservices (Contract Research)
5.3 Agri Biotech
5.4 Industrial Biotech
5.5 Bioinformatics
6. Bio-Clusters: State Driven Initiatives And Policies
6.1 Southern Region
6.1.1 Andhra Pradesh - The Hyderabad Bio-Cluster
6.1.2 Karnataka - The Bangalore Bio-Cluster
6.1.3 Tamil Nadu – The Chennai Biocluster
6.1.4 Kerala
6.2 Western Region
6.2.1 Maharashtra - The Pune Bio-Cluster
6.2.2 Gujarat
6.3 Northern Region
6.3.1 Uttar Pradesh – Lucknow
6.3.2 Punjab
7. Swot Analysis Of Indian Biotechnology Sector
7.1 Strengths
7.2 Weaknesses
7.3 Opportunities
7.4 Threats
8. Key Industry Trends And Opportunities In Indian Biotech Industry
8.1 Recent News And Developments
8.1.1 Serum's biotech SEZ to invest Rs. 1,200 cr.
8.1.2 Tatas invest in 3 biotech SMEs
8.1.3 Pakistan seeks Indian collaboration in biotechnology
8.2 Outsourcing Opportunities
9. Financial Strategy For Emerging Bio-Companies
10. Key Players And Company Profiles
10.1 Biotech Suppliers
10.2 Biotech Companies
10.3 Company Profiles
10.3.1 Biocon
10.3.2 Serum Institute of India
10.3.3 Panacea Biotech
10.3.4 Nicholas Piramal
10.3.5 Wockhardt Limited
10.3.6 GlaxoSmithKline
10.3.7 Bharat Serums
10.3.8 Krebs Biochemical’s & Industries Ltd
10.3.9 Zydus Cadila
10.3.10 Indian Immunologicals
10.3.11 Shantha Biotechnics
10.3.12 Biological E
10.3.13 Chiron Behring Vaccines
10.3.14 Eli Lilly and Company
10.3.15 Novo Nordisk
10.3.16 Mahyco Monsanto
10.3.17 Bharat Biotech
10.3.18 Abbott
10.3.19 Ranbaxy
10.3.20 Novozymes
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: jenniferc@cmsinfo.com
copyright © 2005 all rights reserved
For more information about us, visit CMSinfo.
